Sigma-Aldrich has announced that it has granted Pfizer a worldwide non-exclusive research license to utilize DNA-directed RNAi (ddRNAi) technology. Applications of the ddRNAi technology for research activities have been licensed exclusively by Sigma- Aldrich from Benitec Limited of Australia. This research license provides Pfizer with freedom to use ddRNAi in undertaking research activities throughout its global operations. Financial detai...Wednesday, 3-Jan-2007 / [ Details... ]
Using a new x-ray microscope that can look at nanomaterials in three dimensions, an international research team has produced the first detailed atomic structure of a core-shell nanoparticle. This team, led by Subhash Risbud, Ph.D., at the University of California, Davis, and Jianwei Miao, Ph.D., at the University of California, Los Angeles, published details about this new microscope in the journal Physical Review Letters. The detailed structural information obtained using this device could lead...Monday, 18-Dec-2006 / [ Details... ]
An advisory panel for the Food and Drug Administration (FDA) in the U.S. has recommended that the drug-coated stents used in patients with cardiovascular disease should carry a warning.The panel says the popular stents, which are mesh tubes used to keep arteries open after an angioplasty, are implanted in as many as one million Americans each year.The panel of experts are concerned over two brands in particular Taxus, made by Boston Scientifi...Monday, 11-Dec-2006 / [ Details... ]
FDA will waive rules that prohibit advisory panel members from having financial ties to companies whose products are being reviewed to allow six physicians with ties to Johnson & Johnson and other heart device manufacturers to serve on a panel examining the possible health risks of drug-eluting stents, ...Tuesday, 5-Dec-2006 / [ Details... ]
Typically, researchers create microfluidic devices using the same lithographic techniques and tools used to fabricate computer chips. Lithography is expensive and slow, factors that could limit the ultimate utility of microfluidic devices in clinical applications. Now, investigators at the University of California, Riverside, and Boston University have developed a versatile non-lithographic method capable of printing relatively simple microfluidic devices quickly and inexpensively using a laser ...Monday, 4-Dec-2006 / [ Details... ]
Cleveland Medical Devices has announced that it has been awarded $245,000 in NIH SBIR funding. The proceeds from the grant will fund the development of an Adherence Activity and Outcome Measure Belt that will help researchers quantitatively determine the efficacy of yoga, meditation and other similar alternative medicine techniques as a clinical treatment. Over the long term, the device will have the potential to aid clinicians in assessing pat...Saturday, 2-Dec-2006 / [ Details... ]
FDA on Thursday released recommendations for improving post-market surveillance of medical devices, the AP/Los Angeles Times reports. Safety concerns for post-market monitoring of medical devices "grew after last year's slew of high-profile recalls or safety war...Monday, 13-Nov-2006 / [ Details... ]
In a really interesting study a team of Australian doctors went to the Internet to test the effectiveness and accuracy of the search engine Google when it was presented with a number of symptoms.The doctors based at the Princess Alexandra Hospital in Brisbane 'Googled' the symptoms of 26 cases for a study and in 15 cases, the web search came up with the right diagnosis.Th...Monday, 13-Nov-2006 / [ Details... ]
The U.S. Food and Drug Administration (FDA) has announced its action plan for strengthening the way it monitors the safety of medical devices after they reach the marketplace. "Many of today's medical devices are smaller and more complex than ever, offering new medical opportunities that have benefited literally millions of people," said Scott Gottlieb, M.D., Deputy Commissioner for Medical and Scientific Affairs, FDA. "But this technical sophistica...Monday, 13-Nov-2006 / [ Details... ]
Medford, N.Y.-based Chembio Diagnostics on Monday announced that it has received an order from a Mexican distributor for 990,000 of its rapid HIV test Sure Check HIV 1/2 to screen pregnant women in Mexico, the ...Wednesday, 8-Nov-2006 / [ Details... ]
...Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next...
Total: 803